|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US5643579A
(en)
|
1984-11-01 |
1997-07-01 |
American Home Products Corporation |
Oral vaccines
|
|
ZA858044B
(en)
|
1984-11-01 |
1987-05-27 |
American Home Prod |
Oral vaccines
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US4790987A
(en)
|
1985-11-15 |
1988-12-13 |
Research Corporation |
Viral glycoprotein subunit vaccine
|
|
US5310668A
(en)
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
US5294441A
(en)
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
US5387744A
(en)
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
IL86583A0
(en)
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5112749A
(en)
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
US5225336A
(en)
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
JP3044062B2
(ja)
|
1989-03-08 |
2000-05-22 |
ヘルス・リサーチ・インク |
組換えポックスウイルス宿主選択系
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
AU645489B2
(en)
|
1989-03-31 |
1994-01-20 |
Washington University |
Vaccines containing avirulent phoP-type microorganisms
|
|
ES2070997T3
(es)
|
1989-12-04 |
1995-06-16 |
Akzo Nobel Nv |
Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
|
|
US5294548A
(en)
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5462734A
(en)
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5955088A
(en)
|
1992-02-03 |
1999-09-21 |
Cedars-Sinai Medical Center |
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
|
|
AU4528493A
(en)
|
1992-06-04 |
1994-01-04 |
Regents Of The University Of California, The |
In vivo gene therapy with intron-free sequence of interest
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
PT681483E
(pt)
|
1993-01-26 |
2005-11-30 |
Wyeth Corp |
Composicoes e metodos para distribuicao de material genetico
|
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
NZ267838A
(en)
|
1993-06-07 |
1997-12-19 |
Genentech Inc |
Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains
|
|
US5407073A
(en)
|
1993-10-01 |
1995-04-18 |
Toyo Chemical Co., Ltd. |
Floppy disk container
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US6156319A
(en)
|
1994-07-25 |
2000-12-05 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex vaccine
|
|
NL9401820A
(nl)
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5650309A
(en)
|
1995-05-16 |
1997-07-22 |
The Regents Of The University Of California |
Viral vectors
|
|
US5698202A
(en)
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
|
CA2266656A1
(en)
*
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
|
US6110161A
(en)
|
1997-04-03 |
2000-08-29 |
Electrofect As |
Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
CA2294793A1
(fr)
|
1997-06-30 |
1999-01-14 |
Rhone-Poulenc Rorer S.A. |
Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
|
|
JP2003505114A
(ja)
|
1998-07-13 |
2003-02-12 |
ジェネトロニクス、インコーポレーテッド |
パルス電場による皮膚および筋肉を標的とした遺伝子治療
|
|
US6589529B1
(en)
|
1998-10-30 |
2003-07-08 |
Children's Hospital Medical Center |
Rotavirus subunit vaccine
|
|
ES2257879T3
(es)
|
1998-11-05 |
2006-08-01 |
Powderject Vaccines, Inc. |
Productos de recombinacion de acido nucleico para inmunizacion genetica.
|
|
US6740323B1
(en)
|
1999-11-24 |
2004-05-25 |
Chiron Corporation |
HBV/HCV virus-like particle
|
|
AU2001252458A1
(en)
*
|
2000-05-05 |
2001-11-20 |
Martin Bachmann |
Molecular antigen arrays and vaccines
|
|
US20030138769A1
(en)
*
|
2000-08-16 |
2003-07-24 |
Birkett Ashley J. |
Immunogenic HBc chimer particles having enhanced stability
|
|
JP3543326B2
(ja)
|
2001-08-30 |
2004-07-14 |
ソニー株式会社 |
情報処理装置および方法、情報処理システム、情報配信装置、記録媒体、並びにプログラム
|
|
ATE447967T1
(de)
*
|
2001-09-14 |
2009-11-15 |
Cytos Biotechnology Ag |
Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
|
|
US7045319B2
(en)
|
2001-10-30 |
2006-05-16 |
Ribomed Biotechnologies, Inc. |
Molecular detection systems utilizing reiterative oligonucleotide synthesis
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
ATE538808T1
(de)
*
|
2002-03-28 |
2012-01-15 |
Brenntag Biosector As |
Kombinierte dns/protein impfstoffzusammensetzungen
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
CN100381463C
(zh)
|
2002-09-18 |
2008-04-16 |
中国人民解放军免疫学研究所 |
用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
|
|
US20040175727A1
(en)
|
2002-11-04 |
2004-09-09 |
Advisys, Inc. |
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
|
|
DK2364769T3
(en)
|
2003-05-30 |
2016-04-11 |
Vgxi Inc |
Apparatus and methods for biomaterialeproduktion
|
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
|
KR20050026681A
(ko)
|
2003-09-09 |
2005-03-15 |
학교법인 포항공과대학교 |
서방성 미립구 형태의 ｉｌ-12 면역증강제를 포함하는백신 조성물
|
|
AU2005248361B2
(en)
|
2004-05-18 |
2010-03-11 |
Vical Incorporated |
Influenza virus vaccine composition and methods of use
|
|
WO2006033679A2
(en)
|
2004-05-25 |
2006-03-30 |
Chimeracore, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
WO2008089144A2
(en)
*
|
2007-01-12 |
2008-07-24 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Improved dna vaccination protocols
|
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Ｈｂｖ 백신 및 그의 제조 방법
|
|
WO2008103380A2
(en)
|
2007-02-21 |
2008-08-28 |
Fox Chase Cancer Center |
Hepatitis b virus compositions and methods of use
|
|
WO2008148010A1
(en)
|
2007-05-23 |
2008-12-04 |
Vgx Pharmaceuticals, Inc. |
Composition comprising high concentration of biologically active molecules and processes for preparing the same
|
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
|
AU2008331673B2
(en)
*
|
2007-11-12 |
2014-12-11 |
The Trustees Of The University Of Pennsylvania |
Novel vaccines against multiple subtypes of influenza virus
|
|
WO2009099716A1
(en)
|
2008-01-11 |
2009-08-13 |
Vgx Pharmaceuticals, Inc. |
Novel vaccines against multiple subtypes of dengue virus
|
|
WO2009124312A2
(en)
*
|
2008-04-04 |
2009-10-08 |
The Trustees Of The University Of Pennsylvania |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
|
WO2009130588A2
(en)
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
|
WO2010016071A2
(en)
|
2008-08-05 |
2010-02-11 |
Swati Subodh |
Identification of genomic signature for differentiating highly similar sequence variants of an organism
|
|
WO2010042751A2
(en)
*
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
|
US8829174B2
(en)
|
2008-10-29 |
2014-09-09 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
|
CA2740598C
(en)
*
|
2008-11-17 |
2018-05-22 |
Mathura P. Ramanathan |
Antigens that elicit immune response against flavivirus and methods of using same
|
|
CN101502650B
(zh)
|
2009-03-10 |
2011-12-28 |
邢益平 |
密码子优化的乙型肝炎核酸疫苗
|
|
CA2760315C
(en)
|
2009-04-30 |
2019-05-28 |
Centre Hospitalier Universitaire Vaudois Lausanne (Chuv) |
Modified immunization vectors
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
|
KR101942372B1
(ko)
|
2011-02-11 |
2019-04-12 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
B형 간염 바이러스 코어 단백질을 암호화하는 핵산 분자 및 이를 포함하는 백신
|
|
AP2013007110A0
(en)
|
2011-02-12 |
2013-09-30 |
Globeimmune Inc |
Yeast-based therapeutic for chronic hepatitis B infection
|
|
ES2726348T3
(es)
|
2016-08-16 |
2019-10-03 |
Guangdong Oppo Mobile Telecommunications Corp Ltd |
Sensor de huella dactilar y terminal que lo usa
|